Rare disease agency organizes to help patient advocate facing deportation
Cambridge BioMarketing organized an awareness campaign to support patient advocate Maria Isabel Buseo, who came to the U.S. 16 years ago for a clinical trial.
Policy
Drugmakers want in on Purdue’s bankruptcy settlement to end opioid lawsuits
J&J, Teva, Endo, Allergan and Mallinckrodt have a plan to contribute to the trust created by Purdue’s bankruptcy settlement.
CDC official stresses urgency of investigating vaping to Congress
The CDC’s principal deputy director said “hundreds” of new lung illness cases have been reported since last week.
What 5 states have done on vaping in one week
In the week since the Trump administration proposed banning flavored e-cigarettes, five states have taken action of their own.
Trump administration mulls ban on flavored e-cigarettes
President Trump met with top federal health officials to discuss a response to the teen vaping epidemic.
Juul’s new marketing strategy doesn’t hold up to FDA scrutiny
The FDA sent its first warning letter to Juul after months of efforts to crack down on the company’s marketing tactics.
What politics has done to the healthcare industry’s reputation
The pharma industry fell dead last in Gallup’s latest industry reputation survey.
What’s next after J&J was found responsible for fueling Oklahoma’s opioid crisis
The company predicted its appeal could run through 2021.
FDA, brands caught in the middle of CBD legalization
CBD, or cannabidiol, is a non-psychoactive compound in cannabis. Some claim it has health benefits from easing pain to controlling anxiety, and many Americans are already using it.
FDA says The Real Cost campaign stopped nearly 600,000 from smoking
Its research suggests the push could also help turn the tide against vaping.
